跳至主要内容
临床试验/NCT03676816
NCT03676816已完成不适用

Vaginal Self-sampling for Rapid Turnaround Gonorrhea/Chlamydia Testing in the Emergency Department

University of California, San Francisco1 个研究点 分布在 1 个国家目标入组 533 人开始时间: 2018年9月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
533
试验地点
1
主要终点
Noninferiority of vaginal self-sampling compared to provider performed endocervical sampling for gonorrhea/chlamydia diagnosis

研究概览

简要总结

Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.

详细描述

Study protocol:

  1. Initial emergency department history and physical examination (standard procedure).

a. Provider identifies patient who is felt to require gonorrhea/chlamydia testing.

i. Provider will contact study staff to consent patient. b. Study staff identifies patient who is felt by provider to require gonorrhea/chlamydia testing. i. Study staff will ask provider if they could move forward with consenting patient.

c. Provider who is study staff identifies patient who is felt to require gonorrhea/chlamydia testing. 2. Study staff will attempt to consent patient.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Adult female emergency department patient felt by the provider to require gonorrhea/chlamydia endocervical testing

排除标准

  • •Non-English speakers with the exception of Spanish speakers (once a Spanish-language informed consent document is approved by the Community Medical Center Institutional Review Board)
  • •Age <18 years old
  • •Active psychiatric condition felt to preclude the ability to give informed consent
  • •Treated for gonorrhea/chlamydia within previous four weeks

研究组 & 干预措施

Vaginal self-sampling and provider performed endocervical sampling

Experimental

Patients will take part in both provider-performed endocervical sampling (standard care) and vaginal self-sampling.

干预措施: vaginal self sampling (Procedure)

Vaginal self-sampling and provider performed endocervical sampling

Experimental

Patients will take part in both provider-performed endocervical sampling (standard care) and vaginal self-sampling.

干预措施: provider-performed endocervical sampling (Procedure)

结局指标

主要结局

Noninferiority of vaginal self-sampling compared to provider performed endocervical sampling for gonorrhea/chlamydia diagnosis

时间窗: 2-3 days

In order for vaginal self-sampling to be considered clinically noninferior to the standard provider-performed endocervical sampling method of collection, we established a minimum sensitivity of 90%. This was based on previous research showing Sexually Transmitted Infection (STI) clinicians' top priority for a point of care STI test is a minimum sensitivity of 90%. In addition, a previous ED study examining urine gonorrhea/chlamydia diagnosis using the same point of care test as this study also used a minimum sensitivity of 90%. (9) Thus, our primary outcome measure was examining for the noninferiority of VSS sensitivity for gonorrhea/chlamydia, with noninferiority being demonstrated if the sensitivity is \>=90%.

次要结局

  • Percentage(2-3 days)
  • Numeric(2-3 days)
  • Predictive value(2-3 days)
  • Predictive value-Gonorrhea(2-3 days)
  • Demographics(2-3 days)
  • Predictive value-Chlamydia(2-3 days)
  • Rate-Worried(2-3 days)
  • Rate-Prefer(2-3 days)
  • Descriptive(2-3 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验